BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27377777)

  • 1. A case of multiple recurrence of Clostridium difficile infection with severe hematochezia in an immunocompromised host.
    Zhang X; Chen Y; Gu S; Zheng B; Lv T; Lou Y; Jin J
    Anaerobe; 2016 Dec; 42():31-32. PubMed ID: 27377777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
    Salamonowicz M; Ociepa T; Frączkiewicz J; Szmydki-Baran A; Matysiak M; Czyżewski K; Wysocki M; Gałązka P; Zalas-Więcek P; Irga-Jaworska N; Drożyńska E; Zając-Spychała O; Wachowiak J; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Dembowska-Bagińska B; Chełmecka-Wiktorczyk L; Balwierz W; Bartnik M; Zielezińska K; Urasiński T; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Pierlejewski F; Młynarski W; Gamrot-Pyka Z; Woszczyk M; Małas Z; Badowska W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Gorczyńska E; Jermakow K; Król A; Chybicka A; Ussowicz M; Kałwak K; Styczyński J
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed diagnosis of Clostridium difficile infection; a prospective evaluation of unselected stool samples.
    Reigadas E; Alcalá L; Marín M; Burillo A; Muñoz P; Bouza E
    J Infect; 2015 Mar; 70(3):264-72. PubMed ID: 25452039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection: Early history, diagnosis and molecular strain typing methods.
    Rodriguez C; Van Broeck J; Taminiau B; Delmée M; Daube G
    Microb Pathog; 2016 Aug; 97():59-78. PubMed ID: 27238460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.
    Bruminhent J; Wang ZX; Hu C; Wagner J; Sunday R; Bobik B; Hegarty S; Keith S; Alpdogan S; Carabasi M; Filicko-O'Hara J; Flomenberg N; Kasner M; Outschoorn UM; Weiss M; Flomenberg P
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1329-34. PubMed ID: 24792871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic pitfalls in Clostridium difficile infection.
    Planche T; Wilcox MH
    Infect Dis Clin North Am; 2015 Mar; 29(1):63-82. PubMed ID: 25595842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired Clostridium difficile NAP1/027-associated diarrhea in an eighteen month old child.
    Quesada-Gómez C; Vargas P; López-Ureña D; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E
    Anaerobe; 2012 Dec; 18(6):581-3. PubMed ID: 23116882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study.
    Hensgens MP; Dekkers OM; Demeulemeester A; Buiting AG; Bloembergen P; van Benthem BH; Le Cessie S; Kuijper EJ
    Clin Microbiol Infect; 2014 Dec; 20(12):O1067-74. PubMed ID: 25040463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.
    Jain T; Croswell C; Urday-Cornejo V; Awali R; Cutright J; Salimnia H; Reddy Banavasi HV; Liubakka A; Lephart P; Chopra T; Revankar SG; Chandrasekar P; Alangaden G
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):157-63. PubMed ID: 26211988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK; Housman ST; Burnham CD; Nicolau DP
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.
    Akahoshi Y; Kimura S; Nakano H; Harada N; Kameda K; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Clin Transplant; 2016 Jun; 30(6):703-8. PubMed ID: 27019071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile infection among immunocompromised patients in Rio de Janeiro, Brazil and detection of moxifloxacin resistance in a ribotype 014 strain.
    Secco DA; Balassiano IT; Boente RF; Miranda KR; Brazier J; Hall V; dos Santos-Filho J; Lobo LA; Nouér SA; Domingues RM
    Anaerobe; 2014 Aug; 28():85-9. PubMed ID: 24907488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant.
    Kamboj M; Sheahan A; Sun J; Taur Y; Robilotti E; Babady E; Papanicolaou G; Jakubowski A; Pamer E; Sepkowitz K
    Infect Control Hosp Epidemiol; 2016 Jan; 37(1):8-15. PubMed ID: 26486102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile infection: a comprehensive review.
    Kachrimanidou M; Malisiovas N
    Crit Rev Microbiol; 2011 Aug; 37(3):178-87. PubMed ID: 21609252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.